vs
InfuSystem Holdings, Inc（INFU）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是InfuSystem Holdings, Inc的1.6倍（$57.1M vs $36.2M），REGIS CORP同比增速更快（22.3% vs 7.0%），InfuSystem Holdings, Inc自由现金流更多（$7.0M vs $891.0K），过去两年REGIS CORP的营收复合增速更高（7.8% vs 6.4%）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
INFU vs RGS — 直观对比
营收规模更大
RGS
是对方的1.6倍
$36.2M
营收增速更快
RGS
高出15.2%
7.0%
自由现金流更多
INFU
多$6.1M
$891.0K
两年增速更快
RGS
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $57.1M |
| 净利润 | — | $456.0K |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | 10.8% |
| 净利率 | — | 0.8% |
| 营收同比 | 7.0% | 22.3% |
| 净利润同比 | — | -94.0% |
| 每股收益（稀释后） | $0.09 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURGS
| Q4 25 | $36.2M | $57.1M | ||
| Q3 25 | $36.5M | $59.0M | ||
| Q2 25 | $36.0M | $60.4M | ||
| Q1 25 | $34.7M | $57.0M | ||
| Q4 24 | $33.8M | $46.7M | ||
| Q3 24 | $35.3M | $46.1M | ||
| Q2 24 | $33.7M | $49.4M | ||
| Q1 24 | $32.0M | $49.2M |
净利润INFURGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $2.3M | $1.4M | ||
| Q2 25 | $2.6M | $116.5M | ||
| Q1 25 | $-267.0K | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $1.8M | $-853.0K | ||
| Q2 24 | $717.0K | $91.2M | ||
| Q1 24 | $-1.1M | $-2.3M |
毛利率INFURGS
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURGS
| Q4 25 | 10.3% | 10.8% | ||
| Q3 25 | 10.4% | 10.0% | ||
| Q2 25 | 10.5% | 12.1% | ||
| Q1 25 | 1.8% | 8.8% | ||
| Q4 24 | 7.7% | 11.8% | ||
| Q3 24 | 9.2% | 4.6% | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | -2.6% | 8.3% |
净利率INFURGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | 6.2% | 2.3% | ||
| Q2 25 | 7.2% | 192.9% | ||
| Q1 25 | -0.8% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | 5.1% | -1.9% | ||
| Q2 24 | 2.1% | 184.7% | ||
| Q1 24 | -3.5% | -4.7% |
每股收益（稀释后）INFURGS
| Q4 25 | $0.09 | $0.16 | ||
| Q3 25 | $0.11 | $0.49 | ||
| Q2 25 | $0.12 | $43.67 | ||
| Q1 25 | $-0.01 | $0.08 | ||
| Q4 24 | $0.05 | $2.71 | ||
| Q3 24 | $0.08 | $-0.36 | ||
| Q2 24 | $0.03 | $38.40 | ||
| Q1 24 | $-0.05 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $18.4M |
| 总债务越低越好 | $19.6M | $113.3M |
| 股东权益账面价值 | $57.3M | $188.7M |
| 总资产 | $100.6M | $588.3M |
| 负债/权益比越低杠杆越低 | 0.34× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资INFURGS
| Q4 25 | $3.2M | $18.4M | ||
| Q3 25 | $955.0K | $16.6M | ||
| Q2 25 | $720.0K | $17.0M | ||
| Q1 25 | $1.5M | $13.3M | ||
| Q4 24 | $527.0K | $10.2M | ||
| Q3 24 | $380.0K | $6.3M | ||
| Q2 24 | $146.0K | $10.1M | ||
| Q1 24 | $822.0K | $5.9M |
总债务INFURGS
| Q4 25 | $19.6M | $113.3M | ||
| Q3 25 | $20.9M | $111.3M | ||
| Q2 25 | $26.3M | $110.8M | ||
| Q1 25 | $28.7M | $112.0M | ||
| Q4 24 | $23.9M | $111.5M | ||
| Q3 24 | $28.0M | $95.2M | ||
| Q2 24 | $34.2M | $99.5M | ||
| Q1 24 | $29.9M | $179.7M |
股东权益INFURGS
| Q4 25 | $57.3M | $188.7M | ||
| Q3 25 | $55.5M | $187.6M | ||
| Q2 25 | $54.5M | $185.6M | ||
| Q1 25 | $55.1M | $68.6M | ||
| Q4 24 | $57.5M | $66.7M | ||
| Q3 24 | $55.5M | $56.4M | ||
| Q2 24 | $53.5M | $56.8M | ||
| Q1 24 | $52.3M | $-35.8M |
总资产INFURGS
| Q4 25 | $100.6M | $588.3M | ||
| Q3 25 | $98.9M | $592.1M | ||
| Q2 25 | $100.8M | $599.0M | ||
| Q1 25 | $104.3M | $511.2M | ||
| Q4 24 | $103.6M | $530.1M | ||
| Q3 24 | $105.3M | $508.9M | ||
| Q2 24 | $108.5M | $530.5M | ||
| Q1 24 | $104.8M | $543.7M |
负债/权益比INFURGS
| Q4 25 | 0.34× | 0.60× | ||
| Q3 25 | 0.38× | 0.59× | ||
| Q2 25 | 0.48× | 0.60× | ||
| Q1 25 | 0.52× | 1.63× | ||
| Q4 24 | 0.41× | 1.67× | ||
| Q3 24 | 0.50× | 1.69× | ||
| Q2 24 | 0.64× | 1.75× | ||
| Q1 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $891.0K |
| 自由现金流率自由现金流/营收 | 19.3% | 1.6% |
| 资本支出强度资本支出/营收 | 0.4% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $23.8M | $14.9M |
8季度趋势，按日历期对齐
经营现金流INFURGS
| Q4 25 | $7.1M | $1.7M | ||
| Q3 25 | $8.5M | $2.3M | ||
| Q2 25 | $7.0M | $6.8M | ||
| Q1 25 | $1.8M | $6.2M | ||
| Q4 24 | $7.9M | $2.1M | ||
| Q3 24 | $9.8M | $-1.3M | ||
| Q2 24 | $2.3M | $5.1M | ||
| Q1 24 | $377.0K | $-277.0K |
自由现金流INFURGS
| Q4 25 | $7.0M | $891.0K | ||
| Q3 25 | $8.4M | $1.9M | ||
| Q2 25 | $6.8M | $6.2M | ||
| Q1 25 | $1.6M | $5.9M | ||
| Q4 24 | $7.4M | $1.7M | ||
| Q3 24 | $9.8M | $-1.4M | ||
| Q2 24 | $2.0M | $5.1M | ||
| Q1 24 | $195.0K | $-326.0K |
自由现金流率INFURGS
| Q4 25 | 19.3% | 1.6% | ||
| Q3 25 | 23.1% | 3.2% | ||
| Q2 25 | 18.9% | 10.3% | ||
| Q1 25 | 4.7% | 10.3% | ||
| Q4 24 | 21.9% | 3.6% | ||
| Q3 24 | 27.7% | -3.0% | ||
| Q2 24 | 5.9% | 10.3% | ||
| Q1 24 | 0.6% | -0.7% |
资本支出强度INFURGS
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | 0.6% | 0.9% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 1.6% | 0.9% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 1.0% | 0.0% | ||
| Q1 24 | 0.6% | 0.1% |
现金转化率INFURGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 3.76× | 1.68× | ||
| Q2 25 | 2.70× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | 5.45× | — | ||
| Q2 24 | 3.22× | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
